Чланци са овлашћеним јавним приступом - David StuartСазнајте више
УкупноMRCWellcomeNIHRNIHBBSRCUK Research & InnovationCancer Research UKGatesEuropean CommissionEPSRCHealth Data Research, UKGenome CanadaDOECASBHFGovernment of SpainNSFCAcademy of FinlandNSFDoDRCNFAPESPARCCIHRINSERMHRBVersus Arthritis, UKDFIDSTFCRoyal Society UKDFGHelmholtzSwedish Research CouncilANREDCTPSNSFUSAIDHHMINHMRCNSERCNWOKnut and Alice Wallenberg FoundationA*StarAcademy of Medical Sciences, UKBlood Cancer UKWHOGovernment of ItalyJST
Није доступно нигде: 5
Glycogen phosphorylase b
LN Johnson, J Hajdu, KR Acharya, DI Stuart, PJ McLaughlin, ...
Allosteric enzymes, 81-127, 2020
Овлашћења: UK Medical Research Council
Binding of (5S)-Penicilloic Acid to Penicillin Binding Protein 3
SS van Berkel, JE Nettleship, IKH Leung, J Brem, H Choi, DI Stuart, ...
ACS chemical biology 8 (10), 2112-2116, 2013
Овлашћења: UK Biotechnology and Biological Sciences Research Council, British Heart …
Combined approaches to study virus structures
D Badia-Martinez, HM Oksanen, DI Stuart, NGA Abrescia
Structure and Physics of Viruses: An Integrated Textbook, 203-246, 2013
Овлашћења: Government of Spain
Purification of African swine fever virus
GL Shimmon, PNM Shah, E Fry, DI Stuart, P Hawes, CL Netherton
African Swine Fever Virus: Methods and Protocols, 179-186, 2022
Овлашћења: UK Biotechnology and Biological Sciences Research Council, UK Medical …
Integrative Approaches to Study Virus Structures
DI Stuart, HM Oksanen, NGA Abrescia
Structure and Physics of Viruses: An Integrated Guide, 247-297, 2024
Овлашћења: UK Research & Innovation
Доступно негде: 238
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ...
Nature immunology 21 (11), 1336-1345, 2020
Овлашћења: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera
D Zhou, W Dejnirattisai, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (9), 2348-2361. e6, 2021
Овлашћења: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Antibody status and incidence of SARS-CoV-2 infection in health care workers
SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ...
New England Journal of Medicine 384 (6), 533-540, 2021
Овлашћења: Genome Canada, UK Medical Research Council, National Institute for Health …
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ...
Cell 185 (3), 467-484. e15, 2022
Овлашћења: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Protein production and purification
Architecture et Fonction des Macromolécules Biologiques Vincentelli Renaud 4 ...
Nature methods 5 (2), 135-146, 2008
Овлашћења: Canadian Institutes of Health Research, Genome Canada
Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum
C Liu, HM Ginn, W Dejnirattisai, P Supasa, B Wang, A Tuekprakhon, ...
Cell 184 (16), 4220-4236. e13, 2021
Овлашћења: Bill & Melinda Gates Foundation, US National Institutes of Health, Cancer …
Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum
A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ...
Cell 185 (14), 2422-2433. e13, 2022
Овлашћења: US National Institutes of Health, UK Medical Research Council, National …
Antibody evasion by the P. 1 strain of SARS-CoV-2
W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (11), 2939-2954. e9, 2021
Овлашћења: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
J Huo, A Le Bas, RR Ruza, HME Duyvesteyn, H Mikolajek, T Malinauskas, ...
Nature structural & molecular biology 27 (9), 846-854, 2020
Овлашћења: UK Biotechnology and Biological Sciences Research Council, Cancer Research …
Reduced neutralization of SARS-CoV-2 B. 1.1. 7 variant by convalescent and vaccine sera
P Supasa, D Zhou, W Dejnirattisai, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (8), 2201-2211. e7, 2021
Овлашћења: US National Institutes of Health, Cancer Research UK, UK Medical Research …
The antigenic anatomy of SARS-CoV-2 receptor binding domain
W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn, P Supasa, JB Case, ...
Cell 184 (8), 2183-2200. e22, 2021
Овлашћења: US Department of Defense, US National Institutes of Health, Cancer Research …
Neutralization of SARS-CoV-2 by destruction of the prefusion spike
J Huo, Y Zhao, J Ren, D Zhou, HME Duyvesteyn, HM Ginn, L Carrique, ...
Cell host & microbe 28 (3), 445-454. e6, 2020
Овлашћења: US National Institutes of Health, Cancer Research UK, UK Engineering and …
Reduced neutralisation of SARS-CoV-2 omicron B. 1.1. 529 variant by post-immunisation serum
W Dejnirattisai, RH Shaw, P Supasa, C Liu, ASV Stuart, AJ Pollard, X Liu, ...
Lancet (London, England) 399 (10321), 234, 2021
Овлашћења: UK Medical Research Council, National Institute for Health Research, UK …
Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability
X Wang, SH Li, L Zhu, QG Nian, S Yuan, Q Gao, Z Hu, Q Ye, XF Li, DY Xie, ...
Nature communications 8 (1), 14, 2017
Овлашћења: National Natural Science Foundation of China, Academy of Medical Sciences …
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre …
CD Russell, CJ Fairfield, TM Drake, L Turtle, RA Seaton, DG Wootton, ...
The Lancet Microbe 2 (8), e354-e365, 2021
Овлашћења: Bill & Melinda Gates Foundation, Department of International Development, UK …
Публикације и информације о финансирању аутоматски одређује рачунарски програм